Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers | Healthy Volunteer | Recruiting | Early phase 1 | 2026-09-01 | NCT07774650 | |
| Actinium Therapy for Late-stage Aggressive Sarcomas | Disease Attributes, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm, sarcoma | Recruiting | Phase 1 | 2026-08-28 | NCT07156565 |